...
机译:Pik3CA在循环肿瘤细胞中的突变状态可以在疾病复发或乳腺癌患者的进展过程中改变
Analysis of Circulating Tumor Cells Department of Chemistry University of AthensAthens Greece;
Analysis of Circulating Tumor Cells Department of Chemistry University of AthensAthens Greece;
Analysis of Circulating Tumor Cells Department of Chemistry University of AthensAthens Greece;
Analysis of Circulating Tumor Cells Department of Chemistry University of AthensAthens Greece;
Oncology Unit and Pathology Department Helena Venizelou HospitalAthens Greece;
Oncology Unit and Pathology Department Helena Venizelou HospitalAthens Greece;
Laboratory of Tumor Cell Biology Medical School University of CreteHeraklion Greece;
Analysis of Circulating Tumor Cells Department of Chemistry University of AthensAthens Greece;
机译:Pik3CA在循环肿瘤细胞中的突变状态可以在疾病复发或乳腺癌患者的进展过程中改变
机译:分析转移性乳腺癌患者循环肿瘤细胞中PIK3CA的突变状态
机译:PIK3CA突变状态的改变与内分泌治疗的乳腺癌的复发,转移性疾病或进展无关
机译:使用无标记微流体技术分离转移性结肠直肠癌患者的循环肿瘤细胞进行募准和检测KRA,BRAF,PIK3CA突变
机译:Toll样受体(TLR)的表达和具有循环肿瘤细胞的转移性乳腺癌患者免疫系统细胞的功能。
机译:转移性乳腺癌患者循环肿瘤细胞中单细胞水平上PIK3CA突变状态的异质性
机译:Pik3CA在循环肿瘤细胞中的突变状态可以在疾病复发或乳腺癌患者的进展过程中改变